GR1008161B - Anti-fugal foot liquid - Google Patents

Anti-fugal foot liquid

Info

Publication number
GR1008161B
GR1008161B GR20130100150A GR20130100150A GR1008161B GR 1008161 B GR1008161 B GR 1008161B GR 20130100150 A GR20130100150 A GR 20130100150A GR 20130100150 A GR20130100150 A GR 20130100150A GR 1008161 B GR1008161 B GR 1008161B
Authority
GR
Greece
Prior art keywords
product
perspiration
shoes
fugal
presented
Prior art date
Application number
GR20130100150A
Other languages
Greek (el)
Inventor
Δημητριος Ορεστη Αυλιδης
Original Assignee
Δημητριος Ορεστη Αυλιδης
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Δημητριος Ορεστη Αυλιδης filed Critical Δημητριος Ορεστη Αυλιδης
Priority to GR20130100150A priority Critical patent/GR1008161B/en
Publication of GR1008161B publication Critical patent/GR1008161B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/54Lauraceae (Laurel family), e.g. cinnamon or sassafras

Abstract

There is disclosed a product able to face, in a unique manner, the perspiration of feet enclosed in shoes for hours and, thereby, to eliminate fungi and stench both favored by perspiration conditions. Said anti-fungal product is the only one presented in a liquid form; it is a solution composed of camphor, alcohol, distilled water and formaldehyde (formol). Decades of laboratory experience have demonstrated that the anti-fungal product presented herein is able to suppress once for all (by 80 percent) mycosis-associated problems; it can be locally applied every 15 days on all points of the foot soleenclosed by shoes.
GR20130100150A 2013-03-14 2013-03-14 Anti-fugal foot liquid GR1008161B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GR20130100150A GR1008161B (en) 2013-03-14 2013-03-14 Anti-fugal foot liquid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR20130100150A GR1008161B (en) 2013-03-14 2013-03-14 Anti-fugal foot liquid

Publications (1)

Publication Number Publication Date
GR1008161B true GR1008161B (en) 2014-04-03

Family

ID=50732355

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20130100150A GR1008161B (en) 2013-03-14 2013-03-14 Anti-fugal foot liquid

Country Status (1)

Country Link
GR (1) GR1008161B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998025586A1 (en) * 1996-12-10 1998-06-18 Patricia Dupuy Preparation for dermatological use
KR20110120394A (en) * 2010-04-29 2011-11-04 덕성여자대학교 산학협력단 Antibacterial composition extracted from chrysanthemum morifolium flower

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998025586A1 (en) * 1996-12-10 1998-06-18 Patricia Dupuy Preparation for dermatological use
KR20110120394A (en) * 2010-04-29 2011-11-04 덕성여자대학교 산학협력단 Antibacterial composition extracted from chrysanthemum morifolium flower

Similar Documents

Publication Publication Date Title
CO2017011851A2 (en) Novel compounds
MX2016017355A (en) Lipid comprising docosapentaenoic acid.
DOP2016000195A (en) COMPOUNDS
MX2016002238A (en) Alkynyl alcohols and methods of use.
EA201691911A1 (en) QUICKLY COMPOSITION INSULIN
EA201890883A1 (en) VACUUM DISTILLATION FOR ENRICHING CANNABIDIOL
MX2016002241A (en) Alkynyl alcohols and methods of use.
BR112017013143A2 (en) generation of peroxiformic acid through polyhydric alcohol formate
BR112018008659A2 (en) trisubstituted silylphenoxy heterocycles and analogs
BR112018011526A2 (en) polycyclic compounds as bruton tyrosine kinase inhibitors
BR112016028845A2 (en) compound, pharmaceutical composition and use of a compound
MX2017000827A (en) Sugar compositions for tableting by direct compression.
BR112018010140A2 (en) compounds of formula, composition, use of a compound of formula, method for combating phytopathogenic fungi and seed
MX2016016992A (en) Aptamers specific for tlr-4 and uses thereof.
BR112018010316A2 (en) compounds of formula, composition, use of a compound of formula, method for combating phytopathogenic fungi and seed
UY35986A (en) IMPROVED METHOD FOR THE PRODUCTION OF GINKGO EXTRACTS
CO2019003424A2 (en) Extract impregnated plant of alulosa and method of preparation for the same
NZ730092A (en) Use of cysteamine in treating infections caused by yeasts/moulds
PH12016502544B1 (en) Pharmaceutical preparation containing entecavir as active ingredient, and preparation method therefor
MX2017000829A (en) Sugar compositions for tableting by direct compression.
BR112017014552A2 (en) ? calcitonin analog, and method for producing a decrease in triglycerides in the liver / reduction of fat accumulation in the liver?
MD901Y (en) Process for presowing treatment of cucumber seeds
GR1008161B (en) Anti-fugal foot liquid
BR112017003227A2 (en) compound, pharmaceutical composition and use of a compound
TR201903234T4 (en) Pharmaceutical solution containing dopamine for use in the treatment of Parkinson's disease.

Legal Events

Date Code Title Description
PG Patent granted

Effective date: 20140515